annual EBIT:
$4.84B+$562.80M(+13.17%)Summary
- As of today (June 29, 2025), REGN annual earnings before interest & taxes is $4.84 billion, with the most recent change of +$562.80 million (+13.17%) on December 31, 2024.
- During the last 3 years, REGN annual EBIT has fallen by -$4.55 billion (-48.47%).
- REGN annual EBIT is now -48.47% below its all-time high of $9.38 billion, reached on December 31, 2021.
Performance
REGN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$913.70M-$54.90M(-5.67%)Summary
- As of today (June 29, 2025), REGN quarterly earnings before interest & taxes is $913.70 million, with the most recent change of -$54.90 million (-5.67%) on March 31, 2025.
- Over the past year, REGN quarterly EBIT has increased by +$196.90 million (+27.47%).
- REGN quarterly EBIT is now -75.75% below its all-time high of $3.77 billion, reached on June 30, 2021.
Performance
REGN quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$5.03B+$196.90M(+4.07%)Summary
- As of today (June 29, 2025), REGN TTM earnings before interest & taxes is $5.03 billion, with the most recent change of +$196.90 million (+4.07%) on March 31, 2025.
- Over the past year, REGN TTM EBIT has increased by +$918.90 million (+22.34%).
- REGN TTM EBIT is now -46.37% below its all-time high of $9.38 billion, reached on December 31, 2021.
Performance
REGN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
REGN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.2% | +27.5% | +22.3% |
| 3 y3 years | -48.5% | -15.0% | -45.3% |
| 5 y5 years | +96.6% | +35.4% | +95.0% |
REGN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -48.5% | +13.2% | -44.4% | +27.5% | -45.3% | +22.3% |
| 5 y | 5-year | -48.5% | +96.6% | -75.8% | +35.4% | -46.4% | +95.0% |
| alltime | all time | -48.5% | +2498.2% | -75.8% | +1640.3% | -46.4% | +2595.9% |
REGN EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $913.70M(-5.7%) | $5.03B(+4.1%) |
| Dec 2024 | $4.84B(+13.2%) | $968.60M(-35.7%) | $4.84B(-3.9%) |
| Sep 2024 | - | $1.51B(-8.3%) | $5.03B(+8.1%) |
| Jun 2024 | - | $1.64B(+129.2%) | $4.65B(+13.2%) |
| Mar 2024 | - | $716.80M(-38.5%) | $4.11B(-3.7%) |
| Dec 2023 | $4.27B(-13.1%) | $1.17B(+3.3%) | $4.27B(-4.0%) |
| Sep 2023 | - | $1.13B(+2.4%) | $4.45B(-8.2%) |
| Jun 2023 | - | $1.10B(+25.8%) | $4.84B(+2.7%) |
| Mar 2023 | - | $876.00M(-34.7%) | $4.72B(-4.0%) |
| Dec 2022 | $4.92B(-47.6%) | $1.34B(-12.0%) | $4.92B(-19.3%) |
| Sep 2022 | - | $1.53B(+56.2%) | $6.09B(-4.8%) |
| Jun 2022 | - | $976.30M(-9.2%) | $6.40B(-30.4%) |
| Mar 2022 | - | $1.07B(-57.3%) | $9.19B(-2.1%) |
| Dec 2021 | $9.38B(+142.6%) | $2.52B(+37.5%) | $9.38B(+15.8%) |
| Sep 2021 | - | $1.83B(-51.4%) | $8.11B(+11.0%) |
| Jun 2021 | - | $3.77B(+197.2%) | $7.30B(+63.6%) |
| Mar 2021 | - | $1.27B(+2.3%) | $4.46B(+15.3%) |
| Dec 2020 | $3.87B(+57.3%) | $1.24B(+21.0%) | $3.87B(+9.7%) |
| Sep 2020 | - | $1.02B(+10.3%) | $3.52B(+7.6%) |
| Jun 2020 | - | $928.60M(+37.6%) | $3.28B(+27.0%) |
| Mar 2020 | - | $674.70M(-24.7%) | $2.58B(+4.9%) |
| Dec 2019 | $2.46B(-4.7%) | $896.50M(+15.5%) | $2.46B(+9.5%) |
| Sep 2019 | - | $776.30M(+233.6%) | $2.25B(+6.3%) |
| Jun 2019 | - | $232.70M(-58.0%) | $2.11B(-16.9%) |
| Mar 2019 | - | $553.80M(-19.0%) | $2.54B(-1.5%) |
| Dec 2018 | $2.58B(+22.7%) | $683.60M(+6.3%) | $2.58B(+5.0%) |
| Sep 2018 | - | $643.30M(-3.0%) | $2.46B(+3.0%) |
| Jun 2018 | - | $663.00M(+12.0%) | $2.39B(+5.8%) |
| Mar 2018 | - | $591.80M(+5.5%) | $2.26B(+7.2%) |
| Dec 2017 | $2.10B(+57.3%) | $560.77M(-1.9%) | $2.10B(+11.5%) |
| Sep 2017 | - | $571.79M(+7.6%) | $1.89B(+12.2%) |
| Jun 2017 | - | $531.25M(+20.8%) | $1.68B(+16.5%) |
| Mar 2017 | - | $439.79M(+27.7%) | $1.44B(+8.0%) |
| Dec 2016 | $1.34B(+7.9%) | $344.32M(-6.0%) | $1.34B(+10.8%) |
| Sep 2016 | - | $366.38M(+24.8%) | $1.21B(-2.3%) |
| Jun 2016 | - | $293.51M(-11.8%) | $1.24B(-4.1%) |
| Mar 2016 | - | $332.79M(+55.1%) | $1.29B(+4.0%) |
| Dec 2015 | $1.24B(+55.2%) | $214.53M(-45.6%) | $1.24B(+1.5%) |
| Sep 2015 | - | $394.56M(+13.9%) | $1.22B(+20.0%) |
| Jun 2015 | - | $346.51M(+22.1%) | $1.02B(+14.3%) |
| Mar 2015 | - | $283.73M(+44.7%) | $889.84M(+11.4%) |
| Dec 2014 | $798.61M(+7.5%) | $196.07M(+2.6%) | $798.61M(+0.4%) |
| Sep 2014 | - | $191.06M(-12.8%) | $795.37M(-5.5%) |
| Jun 2014 | - | $218.98M(+13.8%) | $841.74M(+7.7%) |
| Mar 2014 | - | $192.50M(-0.2%) | $781.81M(+5.2%) |
| Dec 2013 | $742.82M(+61.6%) | $192.84M(-18.8%) | $742.82M(+6.7%) |
| Sep 2013 | - | $237.42M(+49.3%) | $696.04M(+5.2%) |
| Jun 2013 | - | $159.06M(+3.6%) | $661.50M(+12.0%) |
| Mar 2013 | - | $153.51M(+5.1%) | $590.42M(+28.4%) |
| Dec 2012 | $459.73M(-328.0%) | $146.05M(-28.0%) | $459.73M(+70.9%) |
| Sep 2012 | - | $202.88M(+130.6%) | $269.07M(+3086.1%) |
| Jun 2012 | - | $87.98M(+285.7%) | $8.45M(-106.1%) |
| Mar 2012 | - | $22.81M(-151.1%) | -$138.85M(-31.1%) |
| Dec 2011 | -$201.61M(+111.4%) | -$44.60M(-22.8%) | -$201.61M(+19.2%) |
| Sep 2011 | - | -$57.74M(-2.7%) | -$169.15M(+18.2%) |
| Jun 2011 | - | -$59.32M(+48.5%) | -$143.04M(+33.9%) |
| Mar 2011 | - | -$39.94M(+229.1%) | -$106.86M(+12.1%) |
| Dec 2010 | -$95.35M(+37.0%) | -$12.14M(-61.6%) | -$95.35M(-19.3%) |
| Sep 2010 | - | -$31.64M(+36.8%) | -$118.13M(+34.6%) |
| Jun 2010 | - | -$23.13M(-18.7%) | -$87.78M(+8.5%) |
| Mar 2010 | - | -$28.44M(-18.6%) | -$80.92M(+19.2%) |
| Dec 2009 | -$69.61M(+0.9%) | -$34.92M(+2604.9%) | -$67.86M(+45.2%) |
| Sep 2009 | - | -$1.29M(-92.1%) | -$46.74M(-28.5%) |
| Jun 2009 | - | -$16.27M(+5.7%) | -$65.38M(-4.9%) |
| Mar 2009 | - | -$15.39M(+11.5%) | -$68.73M(-0.8%) |
| Dec 2008 | -$69.03M(-26.2%) | -$13.79M(-30.8%) | -$69.26M(+50.2%) |
| Sep 2008 | - | -$19.93M(+1.6%) | -$46.10M(-28.9%) |
| Jun 2008 | - | -$19.62M(+23.3%) | -$64.83M(-14.5%) |
| Mar 2008 | - | -$15.91M(-269.9%) | -$75.82M(-19.0%) |
| Dec 2007 | -$93.56M | $9.36M(-124.2%) | -$93.56M(-31.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2007 | - | -$38.67M(+26.3%) | -$136.41M(+8.3%) |
| Jun 2007 | - | -$30.60M(-9.0%) | -$126.00M(+5.3%) |
| Mar 2007 | - | -$33.65M(+0.5%) | -$119.64M(+11.1%) |
| Dec 2006 | -$107.66M(-186.5%) | -$33.49M(+18.5%) | -$107.66M(-174.2%) |
| Sep 2006 | - | -$28.26M(+16.5%) | $145.15M(+4.4%) |
| Jun 2006 | - | -$24.25M(+11.9%) | $139.02M(+6.0%) |
| Mar 2006 | - | -$21.66M(-109.9%) | $131.10M(+5.4%) |
| Dec 2005 | $124.42M(+2103.7%) | $219.31M(-737.8%) | $124.42M(-236.8%) |
| Sep 2005 | - | -$34.39M(+6.9%) | -$90.92M(+37.7%) |
| Jun 2005 | - | -$32.17M(+13.5%) | -$66.01M(+42.0%) |
| Mar 2005 | - | -$28.34M(-813.1%) | -$46.49M(-923.4%) |
| Dec 2004 | $5.65M(-105.6%) | $3.97M(-141.9%) | $5.65M(-136.5%) |
| Sep 2004 | - | -$9.48M(-25.0%) | -$15.47M(-51.2%) |
| Jun 2004 | - | -$12.64M(-153.1%) | -$31.69M(-33.4%) |
| Mar 2004 | - | $23.79M(-238.8%) | -$47.60M(-52.3%) |
| Dec 2003 | -$99.99M(-18.0%) | -$17.14M(-33.3%) | -$99.78M(-14.9%) |
| Sep 2003 | - | -$25.70M(-10.0%) | -$117.27M(-5.2%) |
| Jun 2003 | - | -$28.56M(+0.6%) | -$123.74M(-1.1%) |
| Mar 2003 | - | -$28.38M(-18.1%) | -$125.14M(+2.6%) |
| Dec 2002 | -$121.95M(+42.3%) | -$34.63M(+7.6%) | -$121.95M(+4.3%) |
| Sep 2002 | - | -$32.18M(+7.4%) | -$116.91M(+8.2%) |
| Jun 2002 | - | -$29.95M(+18.9%) | -$108.03M(+12.3%) |
| Mar 2002 | - | -$25.19M(-14.9%) | -$96.17M(+12.2%) |
| Dec 2001 | -$85.68M(+239.0%) | -$29.59M(+27.0%) | -$85.68M(+30.1%) |
| Sep 2001 | - | -$23.29M(+28.8%) | -$65.88M(+13.4%) |
| Jun 2001 | - | -$18.09M(+22.9%) | -$58.07M(+32.4%) |
| Mar 2001 | - | -$14.71M(+50.3%) | -$43.87M(+16.6%) |
| Dec 2000 | -$25.28M(+6.2%) | -$9.79M(-36.8%) | -$37.64M(+31.8%) |
| Sep 2000 | - | -$15.49M(+298.9%) | -$28.55M(+57.2%) |
| Jun 2000 | - | -$3.88M(-54.2%) | -$18.16M(-19.9%) |
| Mar 2000 | - | -$8.48M(+1111.4%) | -$22.68M(-7.8%) |
| Dec 1999 | -$23.80M(+90.4%) | -$700.00K(-86.3%) | -$24.60M(-17.7%) |
| Sep 1999 | - | -$5.10M(-39.3%) | -$29.90M(+9.9%) |
| Jun 1999 | - | -$8.40M(-19.2%) | -$27.20M(+50.3%) |
| Mar 1999 | - | -$10.40M(+73.3%) | -$18.10M(+43.7%) |
| Dec 1998 | -$12.50M(-8.8%) | -$6.00M(+150.0%) | -$12.60M(+8.6%) |
| Sep 1998 | - | -$2.40M(-442.9%) | -$11.60M(+12.6%) |
| Jun 1998 | - | $700.00K(-114.3%) | -$10.30M(-29.9%) |
| Mar 1998 | - | -$4.90M(-2.0%) | -$14.70M(+5.8%) |
| Dec 1997 | -$13.70M(-20.8%) | -$5.00M(+354.5%) | -$13.90M(+3.7%) |
| Sep 1997 | - | -$1.10M(-70.3%) | -$13.40M(-19.8%) |
| Jun 1997 | - | -$3.70M(-9.8%) | -$16.70M(0.0%) |
| Mar 1997 | - | -$4.10M(-8.9%) | -$16.70M(-3.5%) |
| Dec 1996 | -$17.30M(+127.6%) | -$4.50M(+2.3%) | -$17.30M(+11.6%) |
| Sep 1996 | - | -$4.40M(+18.9%) | -$15.50M(+14.8%) |
| Jun 1996 | - | -$3.70M(-21.3%) | -$13.50M(+21.6%) |
| Mar 1996 | - | -$4.70M(+74.1%) | -$11.10M(+30.6%) |
| Dec 1995 | -$7.60M(-74.0%) | -$2.70M(+12.5%) | -$8.50M(-22.0%) |
| Sep 1995 | - | -$2.40M(+84.6%) | -$10.90M(-10.7%) |
| Jun 1995 | - | -$1.30M(-38.1%) | -$12.20M(-41.6%) |
| Mar 1995 | - | -$2.10M(-58.8%) | -$20.90M(-28.4%) |
| Dec 1994 | -$29.20M(-24.7%) | -$5.10M(+37.8%) | -$29.20M(-17.3%) |
| Sep 1994 | - | -$3.70M(-63.0%) | -$35.30M(-13.7%) |
| Jun 1994 | - | -$10.00M(-3.8%) | -$40.90M(+0.5%) |
| Mar 1994 | - | -$10.40M(-7.1%) | -$40.70M(+3.0%) |
| Dec 1993 | -$38.80M(+112.0%) | -$11.20M(+20.4%) | -$39.50M(+14.8%) |
| Sep 1993 | - | -$9.30M(-5.1%) | -$34.40M(+12.1%) |
| Jun 1993 | - | -$9.80M(+6.5%) | -$30.70M(+25.8%) |
| Mar 1993 | - | -$9.20M(+50.8%) | -$24.40M(+32.6%) |
| Dec 1992 | -$18.30M(+90.6%) | -$6.10M(+8.9%) | -$18.40M(+15.0%) |
| Sep 1992 | - | -$5.60M(+60.0%) | -$16.00M(+24.0%) |
| Jun 1992 | - | -$3.50M(+9.4%) | -$12.90M(+13.2%) |
| Mar 1992 | - | -$3.20M(-13.5%) | -$11.40M(+83.9%) |
| Dec 1991 | -$9.60M(+190.9%) | -$3.70M(+48.0%) | -$6.20M(-34.7%) |
| Sep 1991 | - | -$2.50M(+25.0%) | -$9.50M(+66.7%) |
| Jun 1991 | - | -$2.00M(-200.0%) | -$5.70M(+128.0%) |
| Mar 1991 | - | $2.00M(-128.6%) | -$2.50M(-24.2%) |
| Dec 1990 | -$3.30M | -$7.00M(-638.5%) | -$3.30M(-189.2%) |
| Sep 1990 | - | $1.30M(+8.3%) | $3.70M(+54.2%) |
| Jun 1990 | - | $1.20M(0.0%) | $2.40M(+100.0%) |
| Mar 1990 | - | $1.20M | $1.20M |
FAQ
- What is Regeneron Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual EBIT year-on-year change?
- What is Regeneron Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly EBIT year-on-year change?
- What is Regeneron Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals TTM EBIT year-on-year change?
What is Regeneron Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of REGN is $4.84B
What is the all time high annual EBIT for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual earnings before interest & taxes is $9.38B
What is Regeneron Pharmaceuticals annual EBIT year-on-year change?
Over the past year, REGN annual earnings before interest & taxes has changed by +$562.80M (+13.17%)
What is Regeneron Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of REGN is $913.70M
What is the all time high quarterly EBIT for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly earnings before interest & taxes is $3.77B
What is Regeneron Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, REGN quarterly earnings before interest & taxes has changed by +$196.90M (+27.47%)
What is Regeneron Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of REGN is $5.03B
What is the all time high TTM EBIT for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high TTM earnings before interest & taxes is $9.38B
What is Regeneron Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, REGN TTM earnings before interest & taxes has changed by +$918.90M (+22.34%)